8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Dec 27, 2017 · 8y ago · Accession 0001144204-17-065496
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Cue Biopharma, Inc.
- Ticker
- CUE
- CIK
- 1645460
- Form type
- 8-K
- Filing date
- Dec 27, 2017
- Report date
- Dec 27, 2017
- Document
- tv482131_8k.htm
- Size
- 50 KB